Life Sciences Grey Wolf Therapeutics closes oversubscribed $50 million Series B financing expansion 23 May 2024
Life Sciences ICG-backed Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca 14 March 2024
Life Sciences Outlook 2024: A resilient global economy – but geopolitical risks abound 1 December 2023
Life Sciences Unlocking opportunities that have a positive impact on families’ lives 17 February 2023
Life Sciences Amolyt Pharma Announces $138 Million Series C Financing led by Sofinnova Partners and co-led by ICG 6 January 2023
Back